share_log

Phreesia, Inc.'s (NYSE:PHR) P/S Is Still On The Mark Following 43% Share Price Bounce

Phreesia, Inc.'s (NYSE:PHR) P/S Is Still On The Mark Following 43% Share Price Bounce

Phreesia, Inc. 's(纽约证券交易所代码:PHR)在股价反弹43%之后,市盈率仍处于正轨
Simply Wall St ·  2023/12/18 05:16

Phreesia, Inc. (NYSE:PHR) shares have had a really impressive month, gaining 43% after a shaky period beforehand.    Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 32% in the last twelve months.  

Phreesia, Inc.(纽约证券交易所代码:PHR)的股价经历了非常令人印象深刻的一个月,在经历了动荡时期之后上涨了43%。并非所有股东都会感到欢欣鼓舞,因为在过去十二个月中,股价仍下跌了令人失望的32%。

Since its price has surged higher, you could be forgiven for thinking Phreesia is a stock not worth researching with a price-to-sales ratios (or "P/S") of 3.7x, considering almost half the companies in the United States' Healthcare Services industry have P/S ratios below 2x.   Although, it's not wise to just take the P/S at face value as there may be an explanation why it's as high as it is.  

由于其价格飙升,考虑到美国医疗保健服务行业中将近一半的公司的市盈率低于2倍,你认为Phreesia是一只不值得研究的股票,其市售率(或 “市盈率”)为3.7倍,这是可以原谅的。但是,仅按面值计算市盈率是不明智的,因为可以解释为什么市盈率如此之高。

See our latest analysis for Phreesia

查看我们对Phreesia的最新分析

NYSE:PHR Price to Sales Ratio vs Industry December 18th 2023

纽约证券交易所:PHR 价格与销售比率与行业对比 2023 年 12 月 18 日

What Does Phreesia's P/S Mean For Shareholders?

Phreesia的市盈率对股东意味着什么?

With revenue growth that's superior to most other companies of late, Phreesia has been doing relatively well.   The P/S is probably high because investors think this strong revenue performance will continue.  You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.    

由于最近收入增长优于大多数其他公司,Phreesia的表现相对较好。市盈率之所以很高,可能是因为投资者认为这种强劲的收入表现将继续下去。你真的希望如此,否则你将无缘无故地付出相当高的代价。

Keen to find out how analysts think Phreesia's future stacks up against the industry? In that case, our free report is a great place to start.

想了解分析师如何看待Phreesia的未来与该行业背道而驰吗?在这种情况下,我们的免费报告是一个不错的起点。

What Are Revenue Growth Metrics Telling Us About The High P/S?  

收入增长指标告诉我们关于高市盈率的哪些信息?

In order to justify its P/S ratio, Phreesia would need to produce impressive growth in excess of the industry.  

为了证明其市盈率是合理的,Phreesia需要实现超过该行业的惊人增长。

Taking a look back first, we see that the company grew revenue by an impressive 29% last year.    The strong recent performance means it was also able to grow revenue by 142% in total over the last three years.  Therefore, it's fair to say the revenue growth recently has been superb for the company.  

首先回顾一下,我们发现该公司去年的收入增长了令人印象深刻的29%。最近的强劲表现意味着在过去三年中,它的总收入也增长了142%。因此,可以公平地说,该公司最近的收入增长非常好。

Turning to the outlook, the next three years should generate growth of 19%  each year as estimated by the analysts watching the company.  That's shaping up to be materially higher than the 13% each year growth forecast for the broader industry.

谈到前景,根据关注该公司的分析师的估计,未来三年每年将实现19%的增长。这将大大高于整个行业每年13%的增长预期。

With this information, we can see why Phreesia is trading at such a high P/S compared to the industry.  Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.  

有了这些信息,我们可以明白为什么与行业相比,Phreesia的市盈率如此之高。显然,股东们并不热衷于抛售可能展望更繁荣未来的东西。

The Key Takeaway

关键要点

The large bounce in Phreesia's shares has lifted the company's P/S handsomely.      Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.

Phreesia股价的大幅反弹极大地提高了该公司的市盈率。通常,在做出投资决策时,我们会谨慎行事,不要过多地解读市销比率,尽管这可以充分揭示其他市场参与者对公司的看法。

We've established that Phreesia maintains its high P/S on the strength of its forecasted revenue growth being higher than the the rest of the Healthcare Services industry, as expected.  At this stage investors feel the potential for a deterioration in revenues is quite remote, justifying the elevated P/S ratio.  Unless the analysts have really missed the mark, these strong revenue forecasts should keep the share price buoyant.    

我们已经确定,Phreesia之所以能保持较高的市盈率,是因为其预测的收入增长高于医疗保健服务行业的其他行业。在现阶段,投资者认为收入恶化的可能性非常小,这为市盈率上升辩护。除非分析师真的没有达到目标,否则这些强劲的收入预测应该会使股价保持活力。

We don't want to rain on the parade too much, but we did also find 4 warning signs for Phreesia that you need to be mindful of.  

我们不想在游行队伍中下太多雨,但我们也发现了 4 个需要注意的 Phreesia 警告信号。

If these risks are making you reconsider your opinion on Phreesia, explore our interactive list of high quality stocks to get an idea of what else is out there.

如果这些风险使您重新考虑对Phreesia的看法,请浏览我们的优质股票互动清单,以了解还有什么。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接联系我们。或者,也可以发送电子邮件至编辑团队 (at) simplywallst.com。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发